ResearcherLoma Linda UniversityActive in the last 2 years
Tiantian Liu
Matched on ORCID iD 0000-0001-9377-9938; OpenAlex author ID A5100381083. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 3
- Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer. Co-author DOI 10.1126/sciimmunol.adp3978↗
- miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA PaCa-2 GR. Co-author DOI 10.3389/fgene.2024.1393353↗
- Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/pcmedi/pbad004↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Charles Wang · 2 shared papers, 2023–2024 · strength 0.45
- Paper miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA P… DOI 10.3389/fgene.2024.1393353↗
- Paper Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma. DOI 10.1093/pcmedi/pbad004↗
- Ryan N. Fuller · 1 shared paper, 2024 · strength 0.26
- Nathan R. Wall · 1 shared paper, 2024 · strength 0.26
- Zhong Chen · 1 shared paper, 2023 · strength 0.19
- Varintra E. Lander · 1 shared paper, 2025 · strength 0.19
- Graham D. Hogg · 1 shared paper, 2025 · strength 0.19
- William G. Hawkins · 1 shared paper, 2025 · strength 0.19
- Blake E. Sells · 1 shared paper, 2025 · strength 0.19
- Liang‐I Kang · 1 shared paper, 2025 · strength 0.19
- Alyssa G. Weinstein · 1 shared paper, 2025 · strength 0.19
- Roheena Z. Panni · 1 shared paper, 2025 · strength 0.19
- Ryan C Fields · 1 shared paper, 2025 · strength 0.19
- David G DeNardo · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.